信得科技SINDER品牌怎么样 申请店铺

我要投票 信得科技SINDER在兽药行业中的票数:218 更新时间:2025-04-27
信得科技SINDER是哪个国家的品牌?「信得科技SINDER」是 山东信得科技股份有限公司 旗下著名品牌。该品牌发源于山东省潍坊市,在1999年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力信得科技SINDER品牌出海!通过在本页面挂载信得科技SINDER品牌的产品链接和联系方式,可以提高信得科技SINDER产品曝光!跨境电商爆单神器,目前只要100元/年哦~

信得科技SINDER怎么样

山东信得科技股份有限公司,成立于1999年,山东省著名商标,集生物制品/生化制药/兽药制剂/饲料添加剂及兽药原料药的研发、生产和销售于一体的高新技术企业集团


山东信得科技股份有限公司的前身诸城信得药业有限公司成立于1999年4月,公司自成立以来,始终坚持“坚定不移地增加客户价值”的核心理念,实现了持续、健康发展。现已发展成为集研发、生产和销售于一体的企业集团。

目前拥有生物制品、生化制药、兽药制剂、饲料添加剂及兽药原料药五个产品线,集团由山东信得科技股份有限公司,山东信得动物疫苗有限公司、青岛信得药业有限公司、四川华西动物药业有限公司、北京信得威特科技有限公司组成。

集团拥有四个生产基地,其中坐落在诸城开发区的信得生物工业园拥有两个生化制药车间、三个兽药制剂车间、一个原料药合成车间、一个中药提取萃取车间、一个生物酶发酵车间及相应配套设施;北京信得生物制品工厂拥有六条生产线,是国内品种较全的兽用生物制品工厂;山东信得疫苗公司的工厂主要生产高致病性禽流感疫苗;四川华西工厂主要以生产猪药为主,拥有水针、粉针、口服液、中药等多条生产线。

集团拥有两个技术中心,还拥有三个P2实验室、三个国家认证的动物房;P3实验室正在建设之中。

集团研发团队拥有博士、硕士100余名,除了加强自身研发团队建设外,公司联合中国农大、中国农科院、中国兽药监察所、哈兽研、华南农大、青岛农大以及多家兽药企业成立由信得集团担任理事长的中国动物保健产业研发创新联盟,建立了更大的技术创新平台,已经开展的技术合作三十余项;集团还与澳大利亚生物资源公司、法国维克公司、台湾动物疫苗研究所等国际动保公司及研究机构建立了合作关系。

除了在新产品开发上投入很大的资源外,集团还投入巨大的人力物力于动物疫病控制的研究上,集团技术中心设立了猪病和禽病两个实验室,每天对来自全国的病料进行病原分离分析;综合全国的动物疫情设计疾病控制方案,并进行大量的临床试验,以筛选较佳方案;集团还与中国农大赵继勋教授及其研究团队建立了合作关系,跟踪各种传染性疾病的毒株变异,及时改造疫苗毒株。

集团根据服务目标客户设立了八个业务部,实现了技术服务的专业化。八个业务部分别为家禽业务部、家畜业务部、进口疫苗业务部、自产疫苗业务部、国家强制免疫产品业务部、饲料添加剂业务部、原料药业务部、国际业务部。

公司一直把为养殖业提供疾病控制方案作为重要的技术服务支持手段,同时还为合作伙伴提供技术培训、管理咨询等服务支持,帮助合作伙伴做大做强。由于持续的坚持为客户创造价值,信得的品牌得到了养殖业客户的认可。

作为一家富有社会责任感的企业,信得先后为希望工程、抗震救灾等社会公益事业累计捐款、捐物数百万元。


Shandong Xinde Technology Co., Ltd., founded in 1999, is a famous trademark of Shandong Province. Zhucheng Xinde Pharmaceutical Co., Ltd., the predecessor of Shandong Xinde Technology Co., Ltd., was founded in April 1999. Since its establishment, the company has always been Adhering to the core concept of "unswervingly increasing customer value", we have achieved sustained and healthy development. Now it has developed into an enterprise group integrating R & D, production and sales. At present, the group has five product lines of biological products, biochemical pharmaceuticals, veterinary pharmaceutical preparations, feed additives and veterinary drug APIs. The group is composed of Shandong Xinde Technology Co., Ltd., Shandong Xinde animal vaccine Co., Ltd., Qingdao Xinde Pharmaceutical Co., Ltd., Sichuan Huaxi Animal Pharmaceutical Co., Ltd. and Beijing Xinde Weite Technology Co., Ltd. The group has four production bases, including two biochemical pharmaceutical workshops, three veterinary medicine preparation workshops, one API synthesis workshop, one traditional Chinese medicine extraction workshop, one biological enzyme fermentation workshop and corresponding supporting facilities in Xinde bio Industrial Park, which is located in Zhucheng Development Zone; Beijing Xinde bio product factory has six production lines, which are full range of domestic veterinary products Products factory; Shandong Xinde vaccine company's factory mainly produces highly pathogenic avian influenza vaccine; Sichuan Huaxi factory mainly produces swine medicine, with multiple production lines such as water injection, powder injection, oral liquid and traditional Chinese medicine. The group has two technology centers, three P2 laboratories and three national certified animal houses; P3 laboratory is under construction. The R & D team of the group has more than 100 doctors and masters. In addition to strengthening the construction of its own R & D team, the company, together with China Agricultural University, Chinese Academy of Agricultural Sciences, China Veterinary Drug Supervision Institute, Harbin Veterinary Research Institute, South China Agricultural University, Qingdao Agricultural University and a number of veterinary drug enterprises, has established the R & D and innovation alliance of China's animal health industry, with the director of cred group, and established a larger technological innovation platform, More than 30 technical cooperation projects have been carried out; the group has also established cooperation relations with international animal protection companies and research institutions such as Australia biological resources company, France Vick company, Taiwan Animal Vaccine Research Institute, etc. In addition to investing a lot of resources in the development of new products, the group has also invested a lot of manpower and material resources in the research of animal epidemic control. The group technology center has set up two laboratories of pig disease and poultry disease, which carry out pathogen separation and Analysis on disease materials from all over the country every day. The disease control scheme is designed based on the national animal epidemic situation, and a large number of clinical trials are carried out to screen the better prescription The group also established a cooperative relationship with Professor Zhao Jixun and his research team of China Agricultural University to track the strain variation of various infectious diseases and timely modify the vaccine strain. The group has set up eight business departments according to the service target customers, realizing the specialization of technical services. Eight business departments are poultry business department, livestock business department, imported vaccine business department, self produced vaccine business department, national compulsory immunization product business department, feed additive business department, API business department and international business department. The company has always regarded providing disease control programs for the breeding industry as an important technical service support means, and also provided technical training, management consulting and other service support for partners to help them grow bigger and stronger. As a result of continuous adherence to create value for customers, the trusted brand has been recognized by the breeding industry customers. As an enterprise with a sense of social responsibility, trust has donated millions of yuan to hope project, earthquake relief and other social public welfare undertakings.

本文链接: https://brand.waitui.com/10040f1eb.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中金公司:美图生活场景国内付费渗透率达5.2%

36氪获悉,中金公司研报透露,预计截至2月,美图公司生活场景下的国内付费渗透率已经达到5.2%。该场景下的产品包括美图秀秀、美颜相机、Wink等。据研报显示,美图生活场景产品国内付费渗透率突破5%,主要得益于生成式AI对传统功能的重新构建,如用AI去双下巴取代传统的手动推图,带来更好的用户体验和效果,促进订阅转化率提升。美图对生活场景应用订阅渗透率的长期目标为10%。

14分钟前

惠誉博华:商业银行扩表节奏趋缓

36氪获悉,近日惠誉博华商业银行2024年度业绩点评。报告显示,2024年商业银行总资产同比增速回落至4.8%,结束此前连续三年的双位数扩张周期。从银行机构类型看呈现显著分化态势:城商行以8.9%的资产增速领跑,农商行以6.0%的增速紧随其后,国有大行与股份制银行分别录得3.9%和2.7%的增速。这种梯度差异映射出不同类别银行面临的经营环境——头部城商行凭借区域经济韧性维持相对活跃的资产扩张,而股份制银行负债端受制于存款成本刚性约束难以匹配国有大行资金优势,资产端受风险偏好与定价能力限制难以深度渗透区域下沉市场,导致信贷资源配置效率持续承压,近三年资产增速中枢较2019至2021年下降逾6个百分点,信贷市场正从增量竞争向存量优化转换。

14分钟前

EHL酒店管理商学院将举办2025 年首届开放创新峰会

36氪获悉,EHL酒店管理商学院近日宣布,首届 EHL开放创新峰会将于5月20-21日在EHL瑞士洛桑校区举行。据悉本届峰会将围绕食品的未来、再生经济、奢品新义三个主题,打造切实可行的解决方案。EHL创新中心首席执行官Andrea Monti指出:“在这样一个充满活力与变革的时代,酒店及泛服务业对创新的需求比以往任何时候都更为迫切。”

14分钟前

字节启动Top Seed大模型顶尖人才计划2026届校招

36氪获悉,4月27日,字节跳动Seed正式启动2026届Top Seed大模型顶尖人才校招计划。据了解,此前3月Top Seed开放了研究型实习生招聘,今日起正式启动2026届校招,计划招募约30位顶尖应届博士。本届Top Seed研究课题包括大语言模型、机器学习算法和系统、多模态生成、多模态理解、语音等方向,基本覆盖大模型研究各个领域。值得一提的是,本届Top Seed强调不限专业背景,更关注研究潜力,希望寻找具有极强技术信仰与热情、具备出色研究能力、富有好奇心和驱动力的年轻研究者。

14分钟前

硅基智能1000万美元购入DUIX.com域名

近日,AI数字人科技公司硅基智能以1000万美元收购稀缺四字母.com域名DUIX.com,并同步上线同名数字人实时交互平台。据介绍,DUIX,全称Dialogue User Interface System,定位为新一代数字人智能交互基础设施,提供API接入、SDK开发包、免费实时体验入口及多场景应用案例。该平台支持数字人多模态交互,覆盖情感陪伴、客服、教育、医疗、游戏等应用场景,帮助开发者快速搭建实时交互式体验。

14分钟前

本页详细列出关于信得科技SINDER的品牌信息,含品牌所属公司介绍,信得科技SINDER所处行业的品牌地位及优势。
咨询